imiquimod has been researched along with Pneumococcal Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, G; Deng, JC; Ghaffari, AA; Lung, WY; Meyerson, C; Tian, X; Xu, F | 1 |
1 other study(ies) available for imiquimod and Pneumococcal Infections
Article | Year |
---|---|
Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria.
Topics: Aminoquinolines; Animals; Antibodies; Antigens, Viral; Disease Susceptibility; Gene Expression Regulation; Imidazoles; Imiquimod; Interferon Inducers; Interferon Type I; Membrane Proteins; Methicillin-Resistant Staphylococcus aureus; Mice; Nerve Tissue Proteins; Pneumococcal Infections; Pneumonia, Bacterial; Poly I-C; Receptor, Interferon alpha-beta; Receptors, Cell Surface; Signal Transduction; Staphylococcal Infections; Streptococcus pneumoniae; Survival Rate; Toll-Like Receptor 3 | 2012 |